Skip to main content

Diagnostics & Research

Healthcare

31 US-listed companies tracked

Diagnostics & Research companies develop and commercialize lab tests, diagnostic equipment, and research services for hospitals and healthcare systems. Key sensitivities include reimbursement pressures from insurers and Medicare, clinical adoption barriers requiring FDA approval and evidence generation, and competition from larger integrated healthcare companies. TrendMatrix ranks 25 US-listed Diagnostics & Research stocks by 10-dimension quantitative score, refreshed every 5 minutes during market hours with a full reanalysis nightly.

Sort:By verdict tierBy scoreBUY tier first, then score within

Ranked stocks

Diagnostics & Research stocks ranked by TrendMatrix score
#SymbolScoreVerdictPriceUpside
BUY (Strong Buy Now + Strong Buy Wait)
1BLLN6.2Buy Wait$99.39+4.8%
2MEDP6.0Buy Wait$591.29-14.4%
3IDXX5.5Buy Wait$535.38+13.6%
4A5.4Buy Wait$150.86+4.3%
HOLD / WATCH
5CDNA6.3Hold$50.88-7.4%
6VCYT6.3Hold$41.66+18.3%
7WAT5.9Hold$409.38-3.3%
8DHR5.8Hold$207.66-0.8%
9TMO5.5Hold$613.78-7.2%
10LH5.4Hold$326.89-6.0%
11QGEN5.4Hold$43.47-7.8%
SELL
12CSTL6.2Sell$32.91+16.3%
13SHC6.0Sell$18.90+4.6%
14FRNM5.8Sell$16.31-4.0%
15NEO5.7Sell$17.89-1.3%
16GH5.6Sell$162.90+8.3%
17NTRA5.5Sell$328.18-7.7%
18MTD5.3Sell$1345.26-4.8%
19OPK5.3Sell$1.62+126.8%
20FLGT5.2Sell$19.73-18.1%
21RDNT5.2Sell$73.71+11.7%
22DGX5.1Sell$237.14-6.7%
23WGS5.1Sell$84.00-8.5%
24GRAL5.0Sell$80.51-21.6%
25IQV5.0Sell$267.77-7.1%
26RVTY5.0Sell$130.22-15.7%
27ILMN4.8Sell$220.01-18.0%
28ICLR4.6Sell$164.85+1.3%
29PSNL4.6Sell$17.00-23.7%
30ADPT4.5Sell$24.08-10.2%
31CRL4.1Sell$288.50-15.3%

Related Industries

Last updated 7/5/2026 · 31 stocks tracked · Methodology